Road to Recovery: protocol for a mixed-methods prospective cohort study evaluating the impact of a new model of substance use care in a Canadian setting.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 Sep 2024
Historique:
medline: 18 9 2024
pubmed: 18 9 2024
entrez: 17 9 2024
Statut: epublish

Résumé

The Road to Recovery (R2R) Initiative is an innovative model of substance use care that seeks to increase treatment capacity by creating approximately 100 new addiction treatment beds to provide on-demand addiction care in Vancouver, British Columbia, for patients with substance use disorders. The new model also coordinates the region's existing clinical substance use services to support patients across a care continuum that includes traditional office-based addiction treatment and harm reduction services, early withdrawal management and more intensive abstinence-based treatment programming. To understand the impact of offering on-demand and coordinated substance use care, an observational cohort of individuals who access any R2R clinical service will be created to examine health and social outcomes over time. This prospective mixed-methods study will invite individuals from Vancouver, Canada, who access substance use treatment through the R2R model of care to (1) complete a baseline and 12-month follow-up quantitative questionnaire that solicits sociodemographic, substance use and previous addiction treatment data and (2) provide consent to the use of participants' personal identifiers to access health records for chart review and for annual linkage to select health and administrative databases to allow for ongoing (virtual) community follow-up over 5 years. Additionally, a purposive sample of cohort participants will be invited to participate in baseline and 12-month follow-up qualitative interviews to share their experiences accessing R2R and identify challenges and opportunities associated with the implementation of R2R. The study was approved by the University of British Columbia Providence Health Care Research Ethics Board in September 2023. Results from the proposed study will be published in peer-reviewed journals, presented at national and international scientific conferences and disseminated through regular meetings with policymakers, individuals with lived and living experience, and other high-level stakeholders, academic presentations and lay media.

Identifiants

pubmed: 39289021
pii: bmjopen-2024-090608
doi: 10.1136/bmjopen-2024-090608
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e090608

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Brittany B Dennis (BB)

Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada britt.dennis@bccsu.ubc.ca.
British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Jeanette Bowles (J)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Cheyenne Johnson (C)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Travis De Wolfe (T)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Erika Mundel (E)

Providence Health Care Research Institute, Vancouver, British Columbia, Canada.

Danya Fast (D)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Jade Boyd (J)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Medicine, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada.

Mathew Fleury (M)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Providence Health Care Research Institute, Vancouver, British Columbia, Canada.

Paxton Bach (P)

Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Department of Medicine, St Paul's Hospital, Vancouver, British Columbia, Canada.

Nadia Fairbairn (N)

Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.

M Eugenia Socías (ME)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Lianping Ti (L)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Kanna Hayashi (K)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Simon Fraser University Faculty of Health Sciences, Burnaby, British Columbia, Canada.

Kora DeBeck (K)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

M J Milloy (MJ)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Guy Felicella (G)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Jeffrey Morgan (J)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Cameron R Eekhoudt (CR)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Kimberlyn McGrail (K)

Centre for Health Services and Policy Research, University of British Columbia, Vancouver, British Columbia, Canada.

Lindsey Richardson (L)

British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Sociology, University of British Columbia, Vancouver, British Columbia, Canada.

Andrea Ryan (A)

Providence Health Care Research Institute, Vancouver, British Columbia, Canada.

Lawrence Mbuagbaw (L)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Gordon Guyatt (G)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Seonaid Nolan (S)

Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH